Retatrutide mechanism of action and triple receptor activity

Three receptors, one shared second messenger

GIPR, GLP-1R and GCGR are all class B1 G-protein-coupled receptors that couple principally to Gs. Agonist binding activates adenylate cyclase and raises intracellular cyclic AMP, which is why a single readout — cAMP accumulation — can be used to profile activity at all three, in separate cell lines each expressing one receptor.

Because the receptors converge on a common second messenger, a tri-agonist is not delivering three unrelated signals; it is distributing incretin-family signalling across three receptor populations with different tissue distributions. GLP-1R and GIPR are prominent in pancreatic islet and central tissue, while GCGR is prominent in hepatocytes.

Assay formats used in the characterisation literature

• Radioligand or fluorescent competition binding, to establish affinity at each receptor individually.
• cAMP accumulation in receptor-expressing cell lines, the primary potency readout reported for this class.
• β-arrestin recruitment assays, used to describe signalling bias — whether a ligand favours G-protein signalling over arrestin recruitment and receptor internalisation.
• Comparative profiling against native GIP, native GLP-1 and glucagon as reference agonists in the same system.

Why receptor balance is the design variable

The published characterisation of LY3437943 describes an agonist whose potency is not equal at all three receptors — the molecule is deliberately weighted. That weighting, rather than raw potency, is the property under investigation when tri-agonists are compared with dual agonists in the literature.

For in-vitro work this matters practically: a potency value is only interpretable alongside the receptor, the cell line, the reference agonist and the readout used to obtain it. Values from different assay systems are not directly comparable.

Molecular reference

Retatrutide's molecular formula, calculated average mass, pathway classification and lot documentation are recorded in the Pure Helix Molecular Research Index entry for the compound.

Research use

Pure Helix supplies materials for laboratory research use only. Nothing on this page is medical advice, and none of the material described is for human or veterinary use.